Skip to main content
Top

Drugs

Issue 1/2014

Content (13 Articles)

Opioids for Chronic Refractory Breathlessness: Right Patient, Right Route?

  • Current Opinion

David C. Currow, Magnus Ekstrom, Amy P. Abernethy

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

  • Open Access
  • Review Article

Miguel O’Ryan, Jeffrey Stoddard, Daniela Toneatto, James Wassil, Peter M. Dull

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

  • Review Article

George G. Zhanel, Phillip Chung, Heather Adam, Sheryl Zelenitsky, Andrew Denisuik, Frank Schweizer, Philippe R. S. Lagacé-Wiens, Ethan Rubinstein, Alfred S. Gin, Andrew Walkty, Daryl J. Hoban, Joseph P. Lynch 3rd, James A. Karlowsky

Miglustat: A Review of Its Use in Niemann-Pick Disease Type C

  • Adis Drug Evaluation

Katherine A. Lyseng-Williamson

Macitentan: First Global Approval

  • R&D Insight Report

Trina Patel, Kate McKeage

Vortioxetine: First Global Approval

  • R&D Insight Report

Andrew Gibb, Emma D. Deeks

Obinutuzumab: First Global Approval

  • R&D Insight Report

Fiona Cameron, Paul L. McCormack

Erratum to: Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention

  • Erratum

Amany F. Elbehairy, Katherine A. Webb, J. Alberto Neder, Denis E. O’Donnell

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images